| Dr Joseph Kent, MD | |
|
450 E 23rd St, Fremont, NE 68025-9802 | |
| (402) 941-7245 | |
| (402) 941-7248 |
| Full Name | Dr Joseph Kent |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 10 Years |
| Location | 450 E 23rd St, Fremont, Nebraska |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043625023 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 29366 (Nebraska) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Methodist Fremont Health | 7911258520 | 67 |
News Archive
Brainpaths is a BREAKTHROUGH: a Neurological Medical Device that stimulates the sensory cortex of the brain; Brainpaths Medical Device is non-powered, approved for home use and can be purchased without a prescription for under $40.
For women diagnosed with a type of non-invasive breast cancer, removing the breast is not the only treatment option.
LipoScience, Inc., a highly innovative diagnostic company that is advancing patient care by developing high value proprietary blood tests using nuclear magnetic resonance technology, today announced publication of a clinical study in the Journal of Clinical Lipidology demonstrating that in many people, low density lipoprotein cholesterol is a less accurate predictor of cardiovascular disease events than LDL particle number.
New research shows further evidence between COVID-19 infection and the development of long-term neurological symptoms. The findings found COVID-induced neuroinflammation and microvascular injury contributed to dementia-like symptoms. However, they also found evidence indicating a low possibility of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) directly invading the brain.
People with diabetes who appear otherwise healthy may have a six-fold higher risk of developing heart failure regardless of their cholesterol levels, new Johns Hopkins Bloomberg School of Public Health research suggests.
› Verified 3 days ago
| Entity Name | Alegent Creighton Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033288923 PECOS PAC ID: 1850285255 Enrollment ID: O20040326000802 |
News Archive
Brainpaths is a BREAKTHROUGH: a Neurological Medical Device that stimulates the sensory cortex of the brain; Brainpaths Medical Device is non-powered, approved for home use and can be purchased without a prescription for under $40.
For women diagnosed with a type of non-invasive breast cancer, removing the breast is not the only treatment option.
LipoScience, Inc., a highly innovative diagnostic company that is advancing patient care by developing high value proprietary blood tests using nuclear magnetic resonance technology, today announced publication of a clinical study in the Journal of Clinical Lipidology demonstrating that in many people, low density lipoprotein cholesterol is a less accurate predictor of cardiovascular disease events than LDL particle number.
New research shows further evidence between COVID-19 infection and the development of long-term neurological symptoms. The findings found COVID-induced neuroinflammation and microvascular injury contributed to dementia-like symptoms. However, they also found evidence indicating a low possibility of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) directly invading the brain.
People with diabetes who appear otherwise healthy may have a six-fold higher risk of developing heart failure regardless of their cholesterol levels, new Johns Hopkins Bloomberg School of Public Health research suggests.
› Verified 3 days ago
| Entity Name | Faith Regional Physician Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265489157 PECOS PAC ID: 5193786168 Enrollment ID: O20041022000558 |
News Archive
Brainpaths is a BREAKTHROUGH: a Neurological Medical Device that stimulates the sensory cortex of the brain; Brainpaths Medical Device is non-powered, approved for home use and can be purchased without a prescription for under $40.
For women diagnosed with a type of non-invasive breast cancer, removing the breast is not the only treatment option.
LipoScience, Inc., a highly innovative diagnostic company that is advancing patient care by developing high value proprietary blood tests using nuclear magnetic resonance technology, today announced publication of a clinical study in the Journal of Clinical Lipidology demonstrating that in many people, low density lipoprotein cholesterol is a less accurate predictor of cardiovascular disease events than LDL particle number.
New research shows further evidence between COVID-19 infection and the development of long-term neurological symptoms. The findings found COVID-induced neuroinflammation and microvascular injury contributed to dementia-like symptoms. However, they also found evidence indicating a low possibility of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) directly invading the brain.
People with diabetes who appear otherwise healthy may have a six-fold higher risk of developing heart failure regardless of their cholesterol levels, new Johns Hopkins Bloomberg School of Public Health research suggests.
› Verified 3 days ago
| Entity Name | Methodist Fremont Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235618216 PECOS PAC ID: 7911258520 Enrollment ID: O20181017000110 |
News Archive
Brainpaths is a BREAKTHROUGH: a Neurological Medical Device that stimulates the sensory cortex of the brain; Brainpaths Medical Device is non-powered, approved for home use and can be purchased without a prescription for under $40.
For women diagnosed with a type of non-invasive breast cancer, removing the breast is not the only treatment option.
LipoScience, Inc., a highly innovative diagnostic company that is advancing patient care by developing high value proprietary blood tests using nuclear magnetic resonance technology, today announced publication of a clinical study in the Journal of Clinical Lipidology demonstrating that in many people, low density lipoprotein cholesterol is a less accurate predictor of cardiovascular disease events than LDL particle number.
New research shows further evidence between COVID-19 infection and the development of long-term neurological symptoms. The findings found COVID-induced neuroinflammation and microvascular injury contributed to dementia-like symptoms. However, they also found evidence indicating a low possibility of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) directly invading the brain.
People with diabetes who appear otherwise healthy may have a six-fold higher risk of developing heart failure regardless of their cholesterol levels, new Johns Hopkins Bloomberg School of Public Health research suggests.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Joseph Kent, MD 450 E 23rd St, Fremont, NE 68025-9802 Ph: (402) 941-7245 | Dr Joseph Kent, MD 450 E 23rd St, Fremont, NE 68025-9802 Ph: (402) 941-7245 |
News Archive
Brainpaths is a BREAKTHROUGH: a Neurological Medical Device that stimulates the sensory cortex of the brain; Brainpaths Medical Device is non-powered, approved for home use and can be purchased without a prescription for under $40.
For women diagnosed with a type of non-invasive breast cancer, removing the breast is not the only treatment option.
LipoScience, Inc., a highly innovative diagnostic company that is advancing patient care by developing high value proprietary blood tests using nuclear magnetic resonance technology, today announced publication of a clinical study in the Journal of Clinical Lipidology demonstrating that in many people, low density lipoprotein cholesterol is a less accurate predictor of cardiovascular disease events than LDL particle number.
New research shows further evidence between COVID-19 infection and the development of long-term neurological symptoms. The findings found COVID-induced neuroinflammation and microvascular injury contributed to dementia-like symptoms. However, they also found evidence indicating a low possibility of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) directly invading the brain.
People with diabetes who appear otherwise healthy may have a six-fold higher risk of developing heart failure regardless of their cholesterol levels, new Johns Hopkins Bloomberg School of Public Health research suggests.
› Verified 3 days ago